|
SUPT6H expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.776400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.369800E-01 |
| Normal-vs-Stage2 |
1.372390E-01 |
| Normal-vs-Stage3 |
7.921200E-03 |
| Normal-vs-Stage4 |
2.235100E-03 |
| Stage1-vs-Stage2 |
1.368180E-02 |
| Stage1-vs-Stage3 |
5.9731999999979E-05 |
| Stage1-vs-Stage4 |
3.77110000000513E-05 |
| Stage2-vs-Stage3 |
6.835000E-01 |
| Stage2-vs-Stage4 |
3.898200E-01 |
| Stage3-vs-Stage4 |
5.327800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.433830E-01 |
| Normal-vs-AfricanAmerican |
5.942800E-01 |
| Normal-vs-Asian |
1.451360E-01 |
| Caucasian-vs-AfricanAmerican |
1.049360E-01 |
| Caucasian-vs-Asian |
1.867790E-02 |
| AfricanAmerican-vs-Asian |
1.612430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.931900E-02 |
| Normal-vs-Female |
4.247000E-01 |
| Male-vs-Female |
1.280650E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.882800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.792600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.389970E-01 |
| Normal-vs-Age(81-100Yrs) |
1.973810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.908600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.352200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.875200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.287600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.705410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.388600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.11250000003993E-06 |
| Normal-vs-Grade 2 |
5.972400E-01 |
| Normal-vs-Grade 3 |
4.752300E-02 |
| Normal-vs-Grade 4 |
3.795900E-04 |
| Grade 1-vs-Grade 2 |
8.953200E-04 |
| Grade 1-vs-Grade 3 |
2.22000000005274E-06 |
| Grade 1-vs-Grade 4 |
3.60380003616712E-09 |
| Grade 2-vs-Grade 3 |
5.224000E-03 |
| Grade 2-vs-Grade 4 |
1.79625999999766E-05 |
| Grade 3-vs-Grade 4 |
5.112300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.127810E-01 |
| Normal-vs-ccB subtype |
6.180900E-03 |
| ccA subtype-vs-ccB subtype |
1.33719999995119E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.797350E-01 |
| Normal-vs-N1 |
2.591800E-01 |
| N0-vs-N1 |
7.331000E-01 |
|
|
